Prebiotic Inulin for Late-Reproductive Individuals (P.I.L.I. study): A Protocol for a Placebo-Blind, Cross-Over Randomized Controlled Trial
- 1Exercise and Nutrition Sciences Department, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA
Abstract
Background: Perimenopause is a transitional stage preceding menopause, characterized by hormonal fluctuations and physiological changes that may increase cardiometabolic risk. Emerging evidence suggests that the gut microbiome may influence these changes through estrogen metabolism and microbial metabolite production. Inulin, a prebiotic fiber that modulates the gut microbiome, may offer a targeted nutritional strategy; however, its effects during perimenopause remain largely unexplored. Objective: This proof-of-concept study evaluates the effects of short-term inulin supplementation on gut microbiome composition, microbial metabolites, vascular function, skeletal muscle health, and metabolic flexibility in perimenopausal overweight women or with obesity. Methods: We will conduct a randomized, blinded, placebo-controlled crossover trial among 27 women aged 40 to55 years. Participants will receive 10 g/day of inulin and a matched maltodextrin placebo for two 14-day intervention periods separated by a 2 to 4-week washout. We will assess changes in gut and vaginal microbiome composition and functional capacity, stool and plasma microbial metabolites, and circulating markers of estrogen metabolism as primary outcomes. We will also evaluate vascular function, skeletal muscle health and oxidative capacity, and metabolic flexibility as secondary outcomes. Additionally, we will assess physical activity, sleep, dietary intake, perimenopausal symptoms, and intervention feasibility, adherence, acceptability, and tolerability. Conclusion: This study will provide novel insights into the feasibility and biological effects of inulin supplementation on gut-host mechanisms and cardiometabolic health during perimenopause, informing the design of future larger-scale trials. Keywords: Gut Microbiome, Metabolome, Fiber, Women, Prebiotics, Clinical Trial Protocol, Inulin, Perimenopause, Healthy Aging
Related
- Effect of Beetroot Supplementation on Cardiometabolic Risk Factors in Individuals with Prediabetes: Study Protocol for a Randomized Controlled Trial
- Study Protocol for a Randomized Controlled Trial Comparing Swiss Ball Balance Training and Conventional Balance Training to Improve Trunk Control and Mobility in Individuals with Sub acute Stroke.
- Examining the Gastrointestinal Effects of Solnul®, a Prebiotic Resistant Potato Starch: A Replication Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Healthy Adults
- Dietary Enhancement for Iron Deficiency and Anaemia Treatment (DEFeAT): study protocol for a randomised controlled trial to assess the effect of a mineral-enriched powder on iron deficiency in women of reproductive age
- Effects of grip strengthening combined with scapular stabilization exercise on shoulder muscle strength and functional outcomes in individuals with subacromial pain syndrome : A randomized controlled trial
BibTeX
@misc{hajmir2026prebiotic,
title = {{Prebiotic Inulin for Late-Reproductive Individuals (P.I.L.I. study): A Protocol for a Placebo-Blind, Cross-Over Randomized Controlled Trial}},
author = {M. M. Hajmir and S. Smith and M. Ghosh and P. Y. Appiah and A. Ciarglelio and A. Rahnavard and C. P. Ortega-Santos},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.02.26367110},
url = {https://www.medrxiv.org/content/10.64898/2026.11.02.26367110v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Prebiotic Inulin for Late-Reproductive Individuals (P.I.L.I. study): A Protocol for a Placebo-Blind, Cross-Over Randomized Controlled Trial
AU - M. M. Hajmir
AU - S. Smith
AU - M. Ghosh
AU - P. Y. Appiah
AU - A. Ciarglelio
AU - A. Rahnavard
AU - C. P. Ortega-Santos
PY - 2026
DA - 2026/11/02
PB - medRxiv
DO - 10.64898/2026.11.02.26367110
UR - https://www.medrxiv.org/content/10.64898/2026.11.02.26367110v1
AB - Background: Perimenopause is a transitional stage preceding menopause, characterized by hormonal fluctuations and physiological changes that may increase cardiometabolic risk. Emerging evidence suggests that the gut microbiome may influence these changes through estrogen metabolism and microbial metabolite production. Inulin, a prebiotic fiber that modulates the gut microbiome, may offer a targeted nutritional strategy; however, its effects during perimenopause remain largely unexplored. Objective: This proof-of-concept study evaluates the effects of short-term inulin supplementation on gut microbiome composition, microbial metabolites, vascular function, skeletal muscle health, and metabolic flexibility in perimenopausal overweight women or with obesity. Methods: We will conduct a randomized, blinded, placebo-controlled crossover trial among 27 women aged 40 to55 years. Participants will receive 10 g/day of inulin and a matched maltodextrin placebo for two 14-day intervention periods separated by a 2 to 4-week washout. We will assess changes in gut and vaginal microbiome composition and functional capacity, stool and plasma microbial metabolites, and circulating markers of estrogen metabolism as primary outcomes. We will also evaluate vascular function, skeletal muscle health and oxidative capacity, and metabolic flexibility as secondary outcomes. Additionally, we will assess physical activity, sleep, dietary intake, perimenopausal symptoms, and intervention feasibility, adherence, acceptability, and tolerability. Conclusion: This study will provide novel insights into the feasibility and biological effects of inulin supplementation on gut-host mechanisms and cardiometabolic health during perimenopause, informing the design of future larger-scale trials. Keywords: Gut Microbiome, Metabolome, Fiber, Women, Prebiotics, Clinical Trial Protocol, Inulin, Perimenopause, Healthy Aging
ER -